Requirements for control of B-cell lymphoma by NK cells

European Journal of Immunology

Volumn 40, Issue 2, 2010, Pages 494-504

  Brenner, Christoph D ^a   King, Susan ^a   Przewoznik, Margarethe ^a   Wolters, Imke ^a   Adam, Christian ^a   Bornkamm, Georg W ^a   Busch, Dirk H ^a,b   Röcken, Martin ^c   Mocikat, Ralph ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

C myc; Missing self; NK cell activation; NKG2D; Tumor escape

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CANCER CONTROL; CANCER GROWTH; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; EARLY CANCER; IMMUNOSTIMULATION; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 75149162957     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939937     Document Type: Article

References (49)

1. Biron, C. A. and Brossay, L., NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 2001. 13: 458-464.
2. Lanier, L. L., NK cell recognition. Annu. Rev. Immunol. 2005. 23: 225-274.
3. Glas, R., Franksson, L., Une, C., Eloranta, M. L., Ohlén, C., Orn, A. and Kärre, K., Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J. Exp. Med. 2000. 191: 129-138.
4. Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C. and Moretta, L., Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 1996. 14: 619-648.
5. Long, E. O., Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 1999. 17: 875-904.
6. low targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 2003. 19: 561-569.
7. Raulet, D. H., Missing self recognition and self tolerance of natural killer (NK) cells. Semin. Immunol. 2006. 18: 145-150.
8. Lee, K.-M., McNerney, M. E., Stepp, S. E., Mathew, P. A., Schatzle, J. D., Bennett, M. and Kumar, V., 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J. Exp. Med. 2004. 199: 1245-1254.
9. Furukawa, H., Iizuka, K., Poursine-Laurent, J., Shastri, N. and Yokoyama, W. M., A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice. J. Immunol. 2002. 169: 126-136.
10. Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B. and Lanier, L. L., Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002. 296: 1323-1326.
11. Gazit, R., Gruda, R., Elboim, M., Arnon, T. I., Katz, G., Achdout, H., Hanna, J. et al., Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 2006. 7: 517-523.
12. Coudert, J. D. and Held, W., The role of the NKG2D receptor for tumor immunity. Semin. Cancer Biol. 2006. 16: 333-343.
13. Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N. and Raulet, D. H., Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 2000. 1: 119-126.
14. Cerwenka, A., Bakker, A. B., McClanahan, T., Wagner, J., Wu, J., Phillips, J. H. and Lanier, L. L., Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000. 12: 721-727.
15. Carayannopoulos, L. N., Naidenko, O. V., Fremont, D. H. and Yokoyama, W. M., Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 2002. 169: 4079-4083.
16. Diefenbach, A., Jensen, E. R., Jamieson, A. M. and Raulet, D. H., Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001. 413: 165-171.
17. Cerwenka, A., Baron, J. L. and Lanier, L. L., Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 2001. 98: 11521-11526.
18. Jamieson, A. M., Diefenbach, A., McMahon, C. W., Xiong, N., Carlyle, J. R. and Raulet, D. H., The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002. 17: 19-29.
19. Guerra, N., Tan, Y. X., Joncker, N. T., Choy, A., Gallardo, F., Xiong, N., Knoblaugh, S. et al., NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 2008. 28: 571-580.
20. Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S. et al., Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002. 295: 2097-2100.
21. Ciccone, E., Pende, D., Viale, O., Than, A., Donato, C. D., Orengo, A. M., Biassoni, R. et al., Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J. Exp. Med. 1992. 176: 963-971.
22. + T-cellindependent pathway for antitumor CTL induction. Blood 2005. 106: 338-344.
23. Shimizu, K. and Fujii, S., DC therapy induces long-term NK reactivity to tumors via host DC. Eur. J. Immunol. 2009. 39: 457-468.
24. Bryceson, Y. T., March, M. E., Ljunggren, H. G. and Long, E. O., Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006. 107: 159-166.
25. Pende, D., Cantoni, C., Rivera, P., Vitale, M., Castriconi, R., Marcenaro, S., Nanni, M. et al., Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur. J. Immunol. 2001. 31: 1076-1086.
26. North, J., Bakhsh, I., Marden, C., Pittman, H., Addison, E., Navarrete, C., Anderson, R. et al., Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence of a two-stage process in resting NK cell activation. J. Immunol. 2007. 178: 85-94.
27. + T cell pathway. J. Immunol. 2004. 172: 757-761.
28. Hayakawa, Y., Kelly, J. M., Westwood, J. A., Darcy, P. K., Diefenbach, A., Raulet, D. and Smyth, M. J., Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin. J. Immunol. 2002. 169: 5377-5381.
29. Kovalchuk, A. L., Qi, C. F., Torrey, T. A., Taddesse-Heath, L., Feigenbaum, L., Park, S. S., Gerbitz, A. et al., Burkitt lymphoma in the mouse. J. Exp. Med. 2000. 192: 1183-1190.
30. Unni, A. M., Bondar, T. and Medzhitov, R., Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance. Proc. Natl. Acad. Sci. USA 2008. 105: 1686-1691.
31. Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P. and Salazar-Mather, T. P., Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 1999. 17: 189-220.
32. Dokun, A. O., Kim, S., Smith, H. R., Kang, H. S., Chu, D. T. and Yokoyama, W. M., Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2001. 2: 951-956.
33. Costello, R. T., Sivori, S., Marcenaro, E., Lafage-Pochitaloff, M., Mozziconacci, M.-J., Reviron, D., Gastaut, J.-A. et al., Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 2002. 99: 3661-3667.
34. dim natural killer cell subset in patients with cancer. Eur. J. Immunol. 2003. 33: 119-124.
35. Richards, J. O., Chang, X., Blaser, B. W., Caligiuri, M. A., Zheng, P. and Liu, Y., Tumor growth impedes natural-killer-cell maturation in the bone marrow. Blood 2006. 108: 246-252.
36. Ebata, K., Shimizu, Y., Nakayama, Y., Minemura, M., Murakami, J., Kato, T., Yasumura, S. et al., Immature NK cells suppress dendritic cell functions during the development of leukemia in a mouse model. J. Immunol. 2006. 176: 4113-4124.
37. Kovacic, B., Stoiber, D., Moriggl, R.,Weisz, E., Ott, R. G., Kreibich, R., Levy, D. E. et al., STAT1 acts as a tumor promoter for leukemia development. Cancer Cell 2006. 10: 77-87.
38. Fuertes, M. B., Girart, M. V., Molinero, L. L., Domaica, C. I., Rossi, L. E., Barrio,M. M., Mordoh, J. et al., Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity. J. Immunol. 2008. 180: 4606-4614.
39. Groh, V.,Wu, J., Yee, C. and Spies, T., Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002. 419: 734-738.
40. Wiemann, K., Mittrücker, H.-W., Feger, U.,Welte, S. A., Yokoyama,W. M., Spies, T., Rammensee, H.-G. et al., Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J. Immunol. 2005. 175: 720-729.
41. Coudert, J. D., Zimmer, J., Tomasello, E., Cebecauer, M., Colonna, M., Vivier, E. and Held, W., Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood 2005. 106: 1711-1717.
42. Bryceson, Y. T. and Ljunggren, H. G., Tumor cell recognition by the NK cell activating receptor NKG2D. Eur. J. Immunol. 2008. 38: 2957-2961.
43. Andoniou, C. E., Coudert, J. D. and Degli-Esposti, M. A., Killers and beyond: NK-cell-mediated control of immune responses. Eur. J. Immunol. 2008. 38: 2938-2942.
44. Röcken, M., Urban, J. F. and Shevach, E. M., Infection breaks T-cell tolerance. Nature 1992. 359: 79-82.
45. Kim, K. J., Kanellopoulos-Langevin, C., Merwin, R. M., Sachs, D. H. and Asofsky, R., Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 1979. 122: 549-554.
46. Laskov, R. and Scharff, M. D., Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. I. Adaptation of the Merwin plasma cell tumor-11 to culture, cloning, and characterization of gamma globulin subunits. J. Exp. Med. 1970. 131: 515-541.
47. Kiessling, R., Klein, E. andWigzell, H., Natural killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 1975. 5: 112-117.
48. Wolan, D.W., Teyton, L., Rudolph, M. G., Villmow, B., Bauer, S., Busch, D. H. and Wilson, I. A., Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95Å. Nat. Immunol. 2001. 2: 248-254.
49. Busch, D. H., Pilip, I. M., Vijh, S. and Pamer, E. G., Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998. 8: 353-362.